SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marie-Cécile Kienitz, Elisa Mintert-Jancke, Fabian Hertel, Lutz Pott, Differential effects of genetically-encoded Gβγ scavengers on receptor-activated and basal Kir3.1/Kir3.4 channel current in rat atrial myocytes, Cellular Signalling, 2014, 26, 6, 1182

    CrossRef

  2. 2
    Yosuke Okamoto, Koichi Kawamura, Yuta Nakamura, Kyoichi Ono, Pathological impact of hyperpolarization-activated chloride current peculiar to rat pulmonary vein cardiomyocytes, Journal of Molecular and Cellular Cardiology, 2014, 66, 53

    CrossRef

  3. 3
    Stanley Nattel, Niels Voigt, Dobromir Dobrev, Cardiac Electrophysiology: From Cell to Bedside, 2014,

    CrossRef

  4. 4
    Dobromir Dobrev, Niels Voigt, Stanley Nattel, Cardiac Electrophysiology: From Cell to Bedside, 2014,

    CrossRef

  5. 5
    Sandeep V. Pandit, Cardiac Electrophysiology: From Cell to Bedside, 2014,

    CrossRef

  6. 6
    Yanmin Xu, Deepak Sharma, Guangping Li, Yuzhi Liu, Atrial remodeling: New pathophysiological mechanism of atrial fibrillation, Medical Hypotheses, 2013, 80, 1, 53

    CrossRef

  7. 7
    Laurent Macle, Paul Khairy, Atul Verma, Rukshen Weerasooriya, Stephan Willems, Thomas Arentz, Paul Novak, George Veenhuyzen, Christophe Scavée, Allan Skanes, Helmut Puererfellner, Pierre Jaïs, Yaariv Khaykin, Lena Rivard, Peter G. Guerra, Marc Dubuc, Bernard Thibault, Mario Talajic, Denis Roy, Stanley Nattel, Adenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination (ADVICE): Methods and Rationale, Canadian Journal of Cardiology, 2012, 28, 2, 184

    CrossRef

  8. 8
    ARIAN SULTAN, DANIEL STEVEN, THOMAS ROSTOCK, BORIS HOFFMANN, KAI MÜLLERLEILE, HELGE SERVATIUS, IMKE DREWITZ, JAKOB LÜKER, PHILIP MEYER, TUSHAR SALUKHE, STEPHAN WILLEMS, Intravenous Administration of Magnesium and Potassium Solution Lowers Energy Levels and Increases Success Rates Electrically Cardioverting Atrial Fibrillation, Journal of Cardiovascular Electrophysiology, 2012, 23, 1
  9. 9
    Peter Zylbergold, Terence E. Hébert, Kir3 channel signalling complexes in cardiac arrhythmias, Drug Discovery Today: Disease Models, 2012, 9, 3, e97

    CrossRef

  10. 10
    Dobromir Dobrev, Leif Carlsson, Stanley Nattel, Novel molecular targets for atrial fibrillation therapy, Nature Reviews Drug Discovery, 2012, 11, 4, 275

    CrossRef

  11. 11
    S. Nattel, D. Dobrev, The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities, European Heart Journal, 2012, 33, 15, 1870

    CrossRef

  12. 12
    Ralph Lazzara, Ablation: Search and destroy dormant gaps awakened by adenosine, Heart Rhythm, 2011, 8, 9, 1434

    CrossRef

  13. 13
    Deepak Sharma, Guangping Li, Gang Xu, Yuzhi Liu, Yanmin Xu, Atrial Remodeling in Atrial Fibrillation and Some Related MicroRNAs, Cardiology, 2011, 120, 2, 111

    CrossRef

  14. 14
    Heinz Goegelein, Patrick Gautier, Alain Roccon, Stephen O’Connor, Hartmut Ruetten, Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats, Naunyn-Schmiedeberg's Archives of Pharmacology, 2011, 384, 3, 231

    CrossRef

  15. 15
    Z. Wang, Y. Lu, B. Yang, MicroRNAs and atrial fibrillation: new fundamentals, Cardiovascular Research, 2011, 89, 4, 710

    CrossRef

  16. 16
    Yvonne L. Douglas, Monique R.M. Jongbloed, Marco C. DeRuiter, Adriana C. Gittenberger-de Groot, Normal and abnormal development of pulmonary veins: State of the art and correlation with clinical entities, International Journal of Cardiology, 2011, 147, 1, 13

    CrossRef

  17. 17
    Alexander Burashnikov, Charles Antzelevitch, Novel pharmacological targets for the rhythm control management of atrial fibrillation, Pharmacology & Therapeutics, 2011, 132, 3, 300

    CrossRef

  18. 18
    Reza Wakili, Niels Voigt, Stefan Kääb, Dobromir Dobrev, Stanley Nattel, Recent advances in the molecular pathophysiology of atrial fibrillation, Journal of Clinical Investigation, 2011, 121, 8, 2955

    CrossRef

  19. 19
    RISHI ARORA, Sympathetic Imaging with 123-I-MIBG—A New Way to Predict Recurrences After AF Ablation, Journal of Cardiovascular Electrophysiology, 2011, 22, 12
  20. 20
    K. Nishida, A. Maguy, M. Sakabe, P. Comtois, H. Inoue, S. Nattel, The role of pulmonary veins vs. autonomic ganglia in different experimental substrates of canine atrial fibrillation, Cardiovascular Research, 2011, 89, 4, 825

    CrossRef

  21. 21
    Ursula Ravens, Antiarrhythmic therapy in atrial fibrillation, Pharmacology & Therapeutics, 2010, 128, 1, 129

    CrossRef

  22. 22
    Dobromir Dobrev, Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target, Naunyn-Schmiedeberg's Archives of Pharmacology, 2010, 381, 3, 195

    CrossRef

  23. 23
    Niels Voigt, Nadiia Rozmaritsa, Anne Trausch, Thomasz Zimniak, Torsten Christ, Erich Wettwer, Klaus Matschke, Dobromir Dobrev, Ursula Ravens, Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation, Naunyn-Schmiedeberg's Archives of Pharmacology, 2010, 381, 3, 251

    CrossRef

  24. 24
    Ling Xia, Ying-lan Gong, Xiu-wei Zhu, Yu Zhang, Qi Sun, Heng-gui Zhang, Mathematical models of canine right and left atria cardiomyocytes, Journal of Zhejiang University SCIENCE B, 2010, 11, 6, 402

    CrossRef

  25. 25
    Alexander Burashnikov, Charles Antzelevitch, New developments in atrial antiarrhythmic drug therapy, Nature Reviews Cardiology, 2010, 7, 3, 139

    CrossRef

  26. 26
    S.-H. Koo, R. Wakili, J.-H. Heo, D. Chartier, H.-S. Kim, S.-J. Kim, J.-W. Lee, X. Y. Qi, S. Nattel, T.-J. Cha, Role of constitutively active acetylcholine-mediated potassium current in atrial contractile dysfunction caused by atrial tachycardia remodelling, Europace, 2010, 12, 10, 1490

    CrossRef

  27. 27
    Stéphane N. Hatem, Alain Coulombe, Elise Balse, Specificities of atrial electrophysiology: Clues to a better understanding of cardiac function and the mechanisms of arrhythmias, Journal of Molecular and Cellular Cardiology, 2010, 48, 1, 90

    CrossRef

  28. 28
    SuYoung Han, Suzanne J Wilson, Chris P Bolter, Tertiapin-Q removes a mechanosensitive component of muscarinic control of the sinoatrial pacemaker in the rat, Clinical and Experimental Pharmacology and Physiology, 2010, 37, 9
  29. 29
    Niels Voigt, Samy Makary, Stanley Nattel, Dobromir Dobrev, Constitutive Activity in Receptors and Other Proteins, Part A, 2010,

    CrossRef

  30. 30
    Yu Hui Yang, Qiang Sun Zheng, Jun Li, Fu Jun Shang, Tao Liu, Hong Tao Wang, Xiong Tao Liu, Li Liu, Age-related changes in the atrial muscarinic type 2 receptor and their effects on atrial fibrillation vulnerability in rabbits, Experimental Gerontology, 2009, 44, 9, 572

    CrossRef

  31. 31
    Joachim R Ehrlich, Stanley Nattel, Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?, Current Opinion in Cardiology, 2009, 24, 1, 50

    CrossRef

  32. 32
    Zenawit Girmatsion, Peter Biliczki, Angelika Bonauer, Gerhard Wimmer-Greinecker, Mirella Scherer, Anton Moritz, Alicia Bukowska, Andreas Goette, Stanley Nattel, Stefan H. Hohnloser, Joachim R. Ehrlich, Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation, Heart Rhythm, 2009, 6, 12, 1802

    CrossRef

  33. 33
    Juan Tamargo, Eva Delpón, Estimulación vagal y remodelado eléctrico auricular, Revista Española de Cardiología, 2009, 62, 7, 729

    CrossRef

  34. 34
    YAO-CHANG CHEN, NAN-HUNG PAN, CHEN-CHUAN CHENG, SATOSHI HIGA, YI-JEN CHEN, SHIH-ANN CHEN, Heterogeneous Expression of Potassium Currents and Pacemaker Currents Potentially Regulates Arrhythmogenesis of Pulmonary Vein Cardiomyocytes, Journal of Cardiovascular Electrophysiology, 2009, 20, 9
  35. You have free access to this content35
    Alexander Burashnikov, Charles Antzelevitch, New Pharmacological Strategies for the Treatment of Atrial Fibrillation, Annals of Noninvasive Electrocardiology, 2009, 14, 3
  36. 36
    Chris P. Bolter, Michael J. Turner, Tertiapin-Q removes a large and rapidly acting component of vagal slowing of the guinea-pig cardiac pacemaker, Autonomic Neuroscience, 2009, 150, 1-2, 76

    CrossRef

  37. 37
    Brian F. McBride, The Emerging Role of Antiarrhythmic Compounds With Atrial Selectivity in the Management of Atrial Fibrillation, The Journal of Clinical Pharmacology, 2009, 49, 3
  38. 38
    Juan Tamargo, Eva Delpón, Vagal Stimulation and Atrial Electrical Remodeling, Revista Española de Cardiología (English Edition), 2009, 62, 7, 729

    CrossRef

  39. 39
    Shachar Iwanir, Eitan Reuveny, Adrenaline-induced hyperpolarization of mouse pancreatic islet cells is mediated by G protein-gated inwardly rectifying potassium (GIRK) channels, Pflügers Archiv - European Journal of Physiology, 2008, 456, 6, 1097

    CrossRef

  40. 40
    Joachim R. Ehrlich, Peter Biliczki, Stefan H. Hohnloser, Stanley Nattel, Atrial-Selective Approaches for the Treatment of Atrial Fibrillation, Journal of the American College of Cardiology, 2008, 51, 8, 787

    CrossRef

  41. 41
    Dobromir Dobrev, Stanley Nattel, Calcium Handling Abnormalities in Atrial Fibrillation as a Target for Innovative Therapeutics, Journal of Cardiovascular Pharmacology, 2008, 52, 4, 293

    CrossRef

  42. 42
    Antony J. Workman, Kathleen A. Kane, Andrew C. Rankin, Cellular bases for human atrial fibrillation, Heart Rhythm, 2008, 5, 6, S1

    CrossRef

  43. 43
    Joachim R Ehrlich, Hellen Ocholla, Daniel Ziemek, Hartmut Rütten, Stefan H Hohnloser, Heinz Gögelein, Characterization of Human Cardiac Kv1.5 Inhibition by the Novel Atrial-selective Antiarrhythmic Compound AVE1231, Journal of Cardiovascular Pharmacology, 2008, 51, 4, 380

    CrossRef

  44. 44
    Stanley Nattel, Evolving Developments in the Therapeutics of Atrial Fibrillation: Addressing an Unmet Need, Journal of Cardiovascular Pharmacology, 2008, 52, 1, 1

    CrossRef

  45. 45
    Joachim R Ehrlich, Inward Rectifier Potassium Currents as a Target for Atrial Fibrillation Therapy, Journal of Cardiovascular Pharmacology, 2008, 52, 2, 129

    CrossRef

  46. 46
    Hsiang-Ning Luk, Chu-Pin Lo, Hui-Chun Tien, Daniel Lee, Zong-Li Chen, Fei Wang, Shih-Tai Hsin, Yuan-Ji Day, Mechanical Characterization of Rabbit Pulmonary Vein Sleeves in In Vitro Intact Ring Preparation, Journal of the Chinese Medical Association, 2008, 71, 12, 610

    CrossRef

  47. 47
    Jörn Schmitt, Joachim R. Ehrlich, Stefan H. Hohnloser, New Antiarrhythmic Drugs for the Treatment of Atrial Fibrillation, Herz Kardiovaskuläre Erkrankungen, 2008, 33, 8, 562

    CrossRef

  48. 48
    Dobromir Dobrev, New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation, Journal of Interventional Cardiac Electrophysiology, 2008, 22, 2, 107

    CrossRef

  49. 49
    G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, S. Nattel, Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis, Cardiovascular Research, 2008, 81, 3, 491

    CrossRef

  50. 50
    Chang Ahn Seol, Jun Kim, Won Tae Kim, Jeong Mi Ha, Han Choe, Yeon Jin Jang, Eun Bo Shim, Jae Boum Youm, Yung E. Earm, Chae Hun Leem, Simulation of spontaneous action potentials of cardiomyocytes in pulmonary veins of rabbits, Progress in Biophysics and Molecular Biology, 2008, 96, 1-3, 132

    CrossRef

  51. 51
    Chang Ahn Seol, Won Tae Kim, Jeong Mi Ha, Han Choe, Yeon Jin Jang, Jae Boum Youm, Yung E. Earm, Chae Hun Leem, Stretch-activated currents in cardiomyocytes isolated from rabbit pulmonary veins, Progress in Biophysics and Molecular Biology, 2008, 97, 2-3, 217

    CrossRef

  52. 52
    Malini Govindan, Andrei Catanchin, A John Camm, The Place of Hybrid Therapies With Drugs to Supplement Nonpharmacological Therapies in Atrial Fibrillation, Journal of Cardiovascular Pharmacology, 2008, 52, 3, 210

    CrossRef

  53. 53
    Hikaru Tanaka, Norio Hashimoto, A Multiple Ion Channel Blocker, NIP-142, for the Treatment of Atrial Fibrillation, Cardiovascular Drug Reviews, 2007, 25, 4
  54. 54
    Y. Blaauw, H. J. G. M. Crijns, Atrial fibrillation: insights from clinical trials and novel treatment options, Journal of Internal Medicine, 2007, 262, 6
  55. 55
    Y-H Yeh, X Qi, A Shiroshita-Takeshita, J Liu, A Maguy, D Chartier, T Hebert, Z Wang, S Nattel, Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes, British Journal of Pharmacology, 2007, 152, 7
  56. 56
    A F James, J C Hancox, More types than one: multiple muscarinic receptor coupled K+ currents undergo remodelling in an experimental model of atrial fibrillation, British Journal of Pharmacology, 2007, 152, 7
  57. 57
    Elizabeth M. Cherry, Joachim R. Ehrlich, Stanley Nattel, Flavio H. Fenton, Pulmonary vein reentry—Properties and size matter: Insights from a computational analysis, Heart Rhythm, 2007, 4, 12, 1553

    CrossRef

  58. 58
    YI-JEN CHEN, SHIH-ANN CHEN, Electrophysiology of Pulmonary Veins, Journal of Cardiovascular Electrophysiology, 2006, 17, 2
  59. 59
    Stanley Nattel, Leif Carlsson, Innovative approaches to anti-arrhythmic drug therapy, Nature Reviews Drug Discovery, 2006, 5, 12, 1034

    CrossRef

  60. 60
    U. Ravens, E. Wettwer, U. Schotten, R. Weßel, D. Dobrev, Neue Antiarrhythmika in der Therapie des Vorhofflimmerns, Herzschrittmachertherapie & Elektrophysiologie, 2006, 17, 2, 64

    CrossRef

  61. 61
    C. H. Leem, W. T. Kim, J. M. Ha, Y. J. Lee, H. C. Seong, H. Choe, Y. J. Jang, J. B. Youm, Y. E Earm, Simulation of Ca2+-activated Cl- current of cardiomyocytes in rabbit pulmonary vein: implications of subsarcolemmal Ca2+ dynamics, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2006, 364, 1842, 1223

    CrossRef

  62. 62
    Akiko Shiroshita-Takeshita, Bianca J. J. M. Brundel, Stanley Nattel, Atrial Fibrillation: Basic Mechanisms, Remodeling and Triggers, Journal of Interventional Cardiac Electrophysiology, 2005, 13, 3, 181

    CrossRef

  63. 63
    David R. Van Wagoner, Atrial selective strategies for treating atrial fibrillation, Drug Discovery Today: Therapeutic Strategies, 2005, 2, 3, 291

    CrossRef

  64. 64
    M. Zaniboni, F. Cacciani, M. Groppi, Effect of Input Resistance Voltage-Dependency on DC Estimate of Membrane Capacitance in Cardiac Myocytes, Biophysical Journal, 2005, 89, 3, 2170

    CrossRef

  65. 65
    Bianca J.J.M. Brundel, Peter Melnyk, Lena Rivard, Stanley Nattel, The pathology of atrial fibrillation in dogs, Journal of Veterinary Cardiology, 2005, 7, 2, 121

    CrossRef

  66. 66
    Zhiguo Wang, miRNA in the Regulation of Ion Channel/Transporter Expression, Comprehensive Physiology,